Discovery and functional mechanism of novel dipeptidyl peptidase IV inhibitory peptides from Chinese traditional fermented fish (Chouguiyu)

文献类型： 外文期刊

第一作者： Yang, Daqiao

作者： Yang, Daqiao;Li, Chunsheng;Li, Laihao;Wang, Yueqi;Chen, Shengjun;Zhao, Yongqiang;Hu, Xiao;Rong, Hui;Yang, Daqiao;Li, Chunsheng;Li, Laihao;Wang, Yueqi;Chen, Shengjun;Zhao, Yongqiang;Hu, Xiao;Rong, Hui;Yang, Daqiao;Li, Chunsheng;Li, Laihao;Wang, Yueqi;Chen, Shengjun;Zhao, Yongqiang;Hu, Xiao;Rong, Hui

作者机构：

关键词： Chouguiyu; Dipeptidyl peptidase-IV; Peptide; Molecular docking; Hydrophobicity; Hydrogen bond

期刊名称：CURRENT RESEARCH IN FOOD SCIENCE （ 影响因子：6.269； 五年影响因子：6.288 ）

ISSN：

年卷期： 2022 年 5 卷

页码：

收录情况： SCI

摘要： Dipeptidyl peptidase-IV (DPP-IV) inhibitory peptides from fermented foods exhibit great potential to alleviate type 2 diabetes mellitus (T2DM). In this study, the DPP-IV inhibition activity of peptide extract from Chouguiyu was obviously enhanced after 4-8 d fermentation. A total of 125 DPP-IV inhibitory peptides in Chouguiyu were identified by peptidomics and were obtained from 46 precursor proteins, mainly including nebulin, titin, muscle -type creatine kinase, hemoglobin, and actin. After molecular docking with DPP-IV, four novel DPP-IV inhibitory peptides possessing the lowest docking energy were selected, including EPAEAVGDWR (D37), IPHESVDVIK (D22), PDLSKHNNHM (D35), and PFGNTHNNFK (D1). The DPP-IV inhibition activity of D37, D22, D35, and D1 were further verified after synthesis with the IC50 of 0.10 mM, 2.69 mM, 3.88 mM, and 8.51 mM, respectively, in accordance with their docking energies. Energy interaction showed that the structures of EP-, IPH-,-NHM, and PF-in these peptides were easy to connect with DPP-IV enzyme through hydrogen bond, salt bridge, and alkyl. The surface force including the H-bond interaction, hydrophobicity, aromatic interaction, and SAS, played a major role in the interaction between DPP-IV enzyme and peptides. The peptides that possess high hydropho-bicity and can form strong hydrogen bond and salt bridge are potential DPP-IV inhibitory peptides using for T2DM remission.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序